Key result
MediYoga decreased systolic (134 to 127 mmHg; p=0.041) and diastolic blood pressure (79 to 74 mmHg; p=0.005) compared to control, though between-group health-related quality of life did not differ.
Why the study?
Paroxysmal atrial fibrillation impairs health-related quality of life, and while yoga has shown benefit in heart failure and hypertension, its effects in paroxysmal atrial fibrillation were unknown.
Does MediYoga improve health-related quality of life, blood pressure, heart rate, and NT-proBNP in patients with symptomatic paroxysmal atrial fibrillation?
RCT (n=132)
stratified for gender and randomised
Does MediYoga improve health-related quality of life, blood pressure, heart rate, and NT-proBNP in patients with symptomatic paroxysmal atrial fibrillation?
MediYoga may decrease blood pressure and improve within-group health-related quality of life in patients with paroxysmal atrial fibrillation, though between-group differences in quality of life were not significant.
MediYoga reduces blood pressure in paroxysmal AF; extends yoga evidence but leaves quality-of-life benefits open.
Background: Paroxysmal atrial fibrillation is associated with impaired health-related quality of life. Yoga has been suggested to improve health-related quality of life among patients with heart failure and hypertension. Aim: The aim of the study was to evaluate the effects of MediYoga, in respect of health-related quality of life, blood pressure, heart rate, as well as N-terminal pro b-type natriuretic peptide, among patients with symptomatic paroxysmal atrial fibrillation, compared with standard therapy or relaxation. Methods: Patients with symptomatic paroxysmal atrial fibrillation, n=132, were stratified for gender and randomised to MediYoga, a relaxation group or a control group, 44 patients per group with a 12-week follow-up. Health-related quality of life, blood pressure, heart rate and N-terminal pro b-type natriuretic peptide were assessed. Results: After 12 weeks, there were no differences in health-related quality of life between the groups. There were improvements in Short-Form Health Survey bodily pain, general health, social function, mental health and mental component summary scores within the MediYoga group ( p=0.014, p=0.037, p=0.029, p=0.030, p=0.019, respectively). No change was seen in the relaxation and control groups. Systolic blood pressure decreased in the MediYoga group (134±18 to 127±13) compared with the control group (126±17 to 127±15, p=0.041); no difference compared with the relaxation group (131±17 to 125±12). Diastolic blood pressure decreased in the MediYoga group (79±9 to 74 ±9) compared with the control group (76±9 to 79±8, p=0.005); no difference compared with the relaxation group (76±9 to 77±8). There were no differences in heart rate and N-terminal pro b-type natriuretic peptide between the groups after 12 weeks. Conclusions: MediYoga improves health-related quality of life and decreases blood pressure in patients with paroxysmal atrial fibrillation. MediYoga may be used as a part of a self-management programme among patients with paroxysmal atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Wahlström et al. (2019) conducted an RCT in symptomatic paroxysmal atrial fibrillation (n=132). MediYoga vs. standard therapy or relaxation was evaluated on health-related quality of life. MediYoga decreased systolic (134 to 127 mmHg; p=0.041) and diastolic blood pressure (79 to 74 mmHg; p=0.005) compared to control, though between-group health-related quality of life did not differ.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: